A probable case of pregabalin - related reversible hearing loss
Pregabalin and gabapentin are similar compounds with analgesic, anticonvulsant, and anxiolytic characteristics. Due to these pharmacological features, they are commonly used throughout the world in neuropathic pain treatment and anxiety disorders. Mild to moderate side effects of the central nervous system, such as dizziness and somnolence, are important factors in deciding to terminate the use of pregabalin. Studies have also reported that the use of dose-dependent pregabalin resulted in peripheral edema and weight gain. Described in this case report is hearing loss occurring after an increase in the drug dose of a patient using pregabalin.In this case, we wanted to present the occuring hearing-loss after an increase in the drug dose of the patient already using pregabalin.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:32 |
|---|---|
| Enthalten in: |
Agri : Agri (Algoloji) Dernegi'nin Yayin organidir = The journal of the Turkish Society of Algology - 32(2020), 2 vom: 06. Apr., Seite 103-105 |
| Sprache: |
Englisch |
|---|
| Weiterer Titel: |
Pregabaline bağlı gelişen geçici işitme kaybı, beklenmedik bir olgu |
|---|
| Beteiligte Personen: |
Yılmaz, Resul [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 11.01.2021 Date Revised 11.01.2021 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.5505/agri.2018.48753 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM308828550 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM308828550 | ||
| 003 | DE-627 | ||
| 005 | 20231225132559.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.5505/agri.2018.48753 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1029.xml |
| 035 | |a (DE-627)NLM308828550 | ||
| 035 | |a (NLM)32297964 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yılmaz, Resul |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A probable case of pregabalin - related reversible hearing loss |
| 246 | 3 | 3 | |a Pregabaline bağlı gelişen geçici işitme kaybı, beklenmedik bir olgu |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.01.2021 | ||
| 500 | |a Date Revised 11.01.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Pregabalin and gabapentin are similar compounds with analgesic, anticonvulsant, and anxiolytic characteristics. Due to these pharmacological features, they are commonly used throughout the world in neuropathic pain treatment and anxiety disorders. Mild to moderate side effects of the central nervous system, such as dizziness and somnolence, are important factors in deciding to terminate the use of pregabalin. Studies have also reported that the use of dose-dependent pregabalin resulted in peripheral edema and weight gain. Described in this case report is hearing loss occurring after an increase in the drug dose of a patient using pregabalin.In this case, we wanted to present the occuring hearing-loss after an increase in the drug dose of the patient already using pregabalin | ||
| 650 | 4 | |a Case Reports | |
| 650 | 7 | |a Analgesics |2 NLM | |
| 650 | 7 | |a Pregabalin |2 NLM | |
| 650 | 7 | |a 55JG375S6M |2 NLM | |
| 700 | 1 | |a Türk, Şeyda |e verfasserin |4 aut | |
| 700 | 1 | |a Reisli, Ruhiye |e verfasserin |4 aut | |
| 700 | 1 | |a Tuncer Uzun, Sema |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Agri : Agri (Algoloji) Dernegi'nin Yayin organidir = The journal of the Turkish Society of Algology |d 1997 |g 32(2020), 2 vom: 06. Apr., Seite 103-105 |w (DE-627)NLM093697430 |x 2458-9446 |7 nnns |
| 773 | 1 | 8 | |g volume:32 |g year:2020 |g number:2 |g day:06 |g month:04 |g pages:103-105 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.5505/agri.2018.48753 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 32 |j 2020 |e 2 |b 06 |c 04 |h 103-105 | ||